94 related articles for article (PubMed ID: 27259665)
81. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
Yousef GM; Ordon MH; Foussias G; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
[TBL] [Abstract][Full Text] [Related]
82. Gene expression of CD24 core peptide molecule in developing brain and developing non-neural tissues.
Shirasawa T; Akashi T; Sakamoto K; Takahashi H; Maruyama N; Hirokawa K
Dev Dyn; 1993 Sep; 198(1):1-13. PubMed ID: 8292828
[TBL] [Abstract][Full Text] [Related]
83. The evolution of the Sin1 gene product, a little known protein implicated in stress responses and type I interferon signaling in vertebrates.
Wang SZ; Roberts RM
BMC Evol Biol; 2005 Feb; 5():13. PubMed ID: 15698473
[TBL] [Abstract][Full Text] [Related]
84. Analysis of the structure, evolution, and expression of CD24, an important regulator of cell fate.
Ayre DC; Pallegar NK; Fairbridge NA; Canuti M; Lang AS; Christian SL
Gene; 2016 Sep; 590(2):324-37. PubMed ID: 27259665
[TBL] [Abstract][Full Text] [Related]
85. CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Tan Y; Zhao M; Xiang B; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Feb; 50(1):70-83. PubMed ID: 25666875
[TBL] [Abstract][Full Text] [Related]
86. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
87. The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy.
Sagiv E; Arber N
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):125-33. PubMed ID: 19072375
[TBL] [Abstract][Full Text] [Related]
88. Evolutionary aspects of calmodulin.
Friedberg F; Rhoads AR
IUBMB Life; 2001 Apr; 51(4):215-21. PubMed ID: 11569915
[TBL] [Abstract][Full Text] [Related]
89. CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights.
Christian SL
Onco Targets Ther; 2022; 15():1391-1402. PubMed ID: 36425299
[TBL] [Abstract][Full Text] [Related]
90.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
91.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
92.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
94.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
